US Department of Health and Human Services. Cancer Statistics Review 1973–1987. Bethesda, MD: National Cancer Institute, 1990; NIH Pub. No. 90–2789.
Horm JW. An overview of female breast cancer. In: Engstrom PF, Rimer B, Mortenson LE, eds. Advances in Cancer Control: Screening and Prevention Research. New York: Wiley-Liss, Inc., 1990: 217–26.
Devesa SS, Pollack ES, Young JLJr. Assessing the validity of observed cancer incidence trends. Am J Epidemiol 1984; 119: 274–91.
Baker LH. Breast cancer detection demonstration project: Five-year summary report. Ca-Cancer J Clinicians 1982; 32: 194–225.
US Department of Health and Human Services. 1987 Annual Cancer Statistics Review: Including Cancer Trends: 1950–1985. Bethesda, MD: National Cancer Institute, 1988; NIH Pub. No. 88–2789.
Frome EL. The analysis of rates using poisson regression models. Biometrics 1983; 39: 665–74.
McCullagh P, Nelder JA. Generalized Linear Models. New York: Chapman and Hall, 1983.
Little RJA, Pullum TW. The general linear model and direct standardization: A comparison. Sociol Methods Res 1979; 7: 475–501.
Hudson DJ: Fitting segmented curves whose join points have to be estimated. J Amer Statist Assoc 1966; 61: 1097–129.
Lerman PM. Fitting segmented regression models by grid search. Appl Statist 1980; 29: 77–84.
Edwards AWF. Likelihood. Cambridge: Cambridge University Press, 1972.
Petrakis NL, Ernster VL, King M. Breast. In: Schottenfeld D, Fraumeni JFJr., eds. Cancer Epidemiology and Prevention. Philadelphia: WB Saunders, 1982: 855–70.
Thomas LB, Ackerman LV, McDivitt RW, Hanson TAS, Hankey BF, Prorok PC. Report of the NCl ad hoc pathology working group to review the gross and microscopic findings of breast cancer cases in the HIP study. JNCI 1977; 59: 497–541.
Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons, Inc., 1980; 70–117.
Seidman H, Gelb SK, Silverberg E, LaVerda N, Lubera JA. Survival experience in the breast cancer detection demonstration project. Ca-Cancer J Clinicians 1987; 37: 258–90.
US Department of Health and Human Services. US Decennial Life Tables for 1979–81: Vol 1, No 1: United States Life Tables. Hyattsville, MD: National Center for Health Statistics, 1985; DHHS Pub. No. (PHS)85–1150–1.
White EW, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. JNCI 1990; 82: 1546–52.
Roush GC, Holford TR, Schymura MJ, White C. Cancer Risk and Incidence Trends: The Connecticut Perspective. New York: Hemisphere Publishing Corporation, 1987: 223–38.
Hahn RA, Moolgavkar SH. Nulliparity, decade of birth, and breast cancer in Connecticut cohorts, 1855 to 1945: An ecological study. Am J Public Health 1989; 79: 1503–7.
Doll R, Peto R. The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. New York: Oxford University Press, 1981.
Devesa SS, Silverman DT. Cancer incidence and mortality trends in the United States: 1935–74. JNCI 1978; 60: 545–71.
1989 Survey of physicians' attitudes and practices in early cancer detection. Ca-Cancer J Clinicians 1990; 40: 77–101.
Chow WH, Liff JM, Greenberg RS. Mammography in Atlanta. J Med Assoc GA 1987; 76: 788–92.
US Congress, Office of Technology Assessment. Breast cancer screening for Medicare beneficiaries: Effectiveness, costs to Medicare and medical resources required. Unpublished staff paper, November, 1987.
Howard J. Using mammography for cancer control: An untealized potential. Ca-Cancer J Clinicians 1987; 37: 33–48.
Dawson DA, Thompson GB. Breast Cancer Risk Factors and Screening: United States, 1987. Hyattsville, MD: National Center for Health Statistics, 1989; Vital Health Stat 10(172).
Shapiro S, Venet W, Sttax P, Venet L., Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. JNCI 1982; 69: 349–55.
Collette HJA, Day NE, Rombach JJ, De Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet 1984; i: 1224–6.
Verbeek ALM, Hendriks JHCL, Holland R, Mravunae M, Sturmans F, Day NE. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975–1981. Lancet 1984; i: 1222–4.
Baker LH, Chin DY, Wagner KV. Progress in screening for early breast cancer. J Surg Oncol 1985; 30: 96–102.
Tabar L, Fagerberg CJG, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; i: 829–32.
Kessler LG, Feuer EJ, Brown ML. Projections of the breast cancer burden to American women: 1990–2000. Presented at the Workshop on Antiestrogen Prevention of Breast Cancer, Madison, Wisconsin: October 1989.
McWhorter WP, Eyre HJ. Impact of mammographic screening on breast cancer diagnosis. JNCI 1990; 82: 153–4.
Blot WJ, Devesa SS, Fraumeni JFJr. Declining breast cancer mortality among young American women. JNCI 1987; 78: 451–4.
White E. Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Public Health 1987; 77: 495–7.
Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: Possible modifying effect of formulation and age at use. Lancet 1983; ii: 926–30.
McPherson K, Neil A, Vessey MP, Doll R. Oral contraceptives and breast cancer. Lancet 1983; ii: 1414–5.
Meirik O, Lund E, Adami HO, Bergstrom R. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet 1986; ii: 650–4.
McPherson K, Vessey MP, Neil A, Doll R, Jones L, Roberts M. Early contraceptive use and breast cancer: Results of another case-control study. Br J Cancer 1987; 56: 653–60.
Kay CR, Hannaford PC. Oral contraceptives and the pill—A further report from the Royal College of General Practitioners' oral contraception study. Br J Cancer 1988; 58: 675–80.
Stadel BV, Lai S, Schlesselman JJ, Murray P. Oral contraceptives and premenopaual breast cancer in nulliparous women. Contraception 1988; 38: 287–99.
Miller DR, Rosenberg L, Kaufman DW, Stolley P, Warshauer ME, Shapiro S. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989; 129: 269–80.
Olsson H, Moller TR, Ranstam J. Early oral contraceptive use and breast cancer among premenopausal women: Final report from a study in southern Sweden. JCNI 1989; 81: 1000–4.
Stadel BV, Schlesselman JJ. Oral contraceptives and breast cancer. Lancet 1986; ii: 922–3.
Paul C, Skegg DC, Spears GF, Kaldor JM. Oral contraceptives and breast cancer: a national study. Br Med J 1986; 293: 723–6.
Miller DR, Rosenberg L, Kaufman DW, Schottennfeld D, Stolley PD, Shapiro S. Breast cancer risk in relation to early oral contraceptive use. Obstet Gynecol 1986; 68: 863–8.